Johnson & Johnson
In mid-October, the Drip Portfolio made its second purchase decision as it decided to begin investing in health care leader Johnson & Johnson. The money was sent to purchase the share and enroll in Intel's DRP plan during the middle of the month. A graph above will reflect the stock's performance over the coming years, beginning from the portfolio's decision to start buying the company. The collection of articles linked below takes the reader through the thought process leading to the purchase.
Johnson & Johnson News & Information
10/08/97 - Buy Announcement
On November 14, 1997, the Drip Portfolio "reviewed the patient's charts" and made its second purchase decision when it bought the stock of the leading health care product manufacturer, Johnson & Johnson (NYSE: JNJ).
For full rationale behind the purchase, please see the collection of recaps on Johnson & Johnson leading to the decision.
ACTION # STOCK PRICE COMS'N COST Bought 1 JNJ $62.125 $15.00 $77.125
More from The Motley Fool
It's Been a Wild Week for Cryptocurrencies -- Have They Finally Stabilized?
After a volatile start to the week, the major cryptocurrencies seem to have settled down.
Should You Buy Financial Stocks in 2018?
The financial sector did well last year, and the run may not be over.
Better Buy: Intel Corporation vs. NVIDIA
The two companies are vying for processor dominance.